Skip to main navigation Skip to search Skip to main content

Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies under Medicare Part D

  • Colette Dejong
  • , Camlyn Masuda
  • , Randi Chen
  • , Dhruv S. Kazi
  • , R. Adams Dudley
  • , Chien Wen Tseng

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1696-1699
Number of pages4
JournalJAMA Internal Medicine
Volume180
Issue number12
Early online dateAug 14 2020
DOIs
StatePublished - Dec 2020

Bibliographical note

Funding Information:
Funding/Support: This research was funded in part by a National Institutes of Health/National Center for Advancing Translational Sciences flagship Clinical and Translational Science grant (UL1 TR001114).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this